Medication-error prevention
Methotrexate tablets: make the dosing day explicit
The arithmetic can be right while the schedule is dangerous. Oral methotrexate for rheumatoid arthritis is a useful example: the number of tablets, the interval and the indication must agree. The May 2026 label warns that daily administration of a prescribed weekly dose has caused deaths.
Sources checked October 6, 2026. Independent educational content, not NABP exam questions or individual treatment advice.
Start with the indication and schedule
The cited tablet label gives a once-weekly starting regimen for rheumatoid arthritis. Other indications include oncology regimens with different schedules, so do not turn the rule into a claim that every methotrexate prescription is once weekly.
Match the indication, route, formulation, dose and interval. When the prescription, history and label disagree, preserve the disagreement and contact the prescriber through the clinical workflow. Guessing which field is a typo is unsafe.
Keep tablet count separate from frequency
A total dose of 15 mg using 2.5 mg tablets requires six tablets for that dose. This calculation says nothing about whether six tablets should be taken daily, weekly or according to an oncology protocol.
Write the day and interval clearly and use teach-back. Asking the patient when the next dose will be taken can uncover an interpretation that a correct-looking label or a simple yes/no counseling question misses.
Recognize the warning beyond the schedule
The May 2026 label includes a boxed warning about medication errors and serious adverse reactions. Bone marrow, gastrointestinal, liver, lung, skin and kidney adverse effects require the monitoring and response described in the full label.
For non-neoplastic disease, pregnancy is a contraindication in this label. Review pregnancy status where relevant, interactions and the clinical monitoring plan. A corrected interval is one safety check, not the end of the assessment.
Escalate possible repeated exposure
If someone has already taken a weekly dose on successive days, do not limit the response to replacing the label for the next refill. Recover the actual dose, dates and symptoms and arrange urgent clinical assessment through appropriate local services.
Do not invent a rescue regimen from a short teaching case. The important exam distinction is between preventing an error before supply and assessing possible harm after exposure.
A worked case
A rheumatoid-arthritis prescription says methotrexate 15 mg daily. The documented treatment plan says 15 mg once weekly on Fridays. Tablets are 2.5 mg. The patient has not started the new supply.
- Six tablets would make one 15 mg dose, but the tablet count does not resolve the interval conflict.
- Identify daily versus weekly as a potentially fatal medication error and clarify before supply.
- Once the regimen is confirmed, make the weekly day clear and ask the patient to explain the next dose date.
Answer: Stop and clarify the interval; do not dispense a mathematically correct daily instruction.
Try it before reading the answer
Write the key fact, decision and safety check first. These are original practice exercises, not recalled exam items.
1. How many 2.5 mg tablets make one 15 mg dose?
Six. This answer does not authorize the frequency.
2. Is every methotrexate regimen necessarily weekly?
No. Verify indication and protocol; oncology schedules can differ.
3. Is changing tomorrow's label enough after several daily doses?
No. Possible excess exposure requires urgent clinical assessment, not only a future label correction.
Continue learning
Put the topic into a study planSources and scope
Source dates and limits matter. Follow the current official source for clinical or regulatory decisions. Examples are simplified teaching cases, not prescribing, diagnostic or compounding instructions. Check the full current guidance and individual clinical context.